|
1
|
Ministry of Health, PCR. Chinese Health
Statistical Digest. 2010, Available from: http://www.moh.gov.cn/publicfiles//business/htmlfiles/zwgkzt/ptjty/digest2010/index.html.
|
|
2
|
Alazzouzi H, Alhopuro P, Salovaara R,
Sammalkorpi H, Jarvinen H, Mecklin JP, Hemminki A, Schwartz S Jr,
Aaltonen LA and Arango D: SMAD4 as a prognostic marker in
colorectal cancer. Clin Cancer Res. 11:2606–2611. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Basseres DS, D’Alo F, Yeap BY, Lowenberg
EC, Gonzalez DA, Yasuda H, Dayaram T, Kocher ON, Godleski JJ,
Richards WG, Meyerson M, Kobayashi S, Tenen DG, Halmos B and Costa
DB: Frequent downregulation of the transcription factor Foxa2 in
lung cancer through epigenetic silencing. Lung Cancer. 77:31–37.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bockmuhl U, Schmidt S, Petersen S and
Petersen I: Deletion of chromosome 10q - a marker for metastasis of
head-neck carcinomas? Laryngorhinootologie. 79:81–85. 2000.(In
German).
|
|
5
|
Bosch LJ, Oort FA, Neerincx M, Khalid-de
Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee
AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupe
VM, Mulder CJ, van Engeland M, Carvalho B and Meijer GA: DNA
methylation of phosphatase and actin regulator 3 detects colorectal
cancer in stool and complements FIT. Cancer Prev Res. 5:464–472.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dellas A, Torhorst J, Jiang F, Proffitt J,
Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ and Moch H:
Prognostic value of genomic alterations in invasive cervical
squamous cell carcinoma of clinical stage IB detected by
comparative genomic hybridization. Cancer Res. 59:3475–3479.
1999.PubMed/NCBI
|
|
7
|
Diep CB, Kleivi K, Ribeiro FR, Teixeira
MR, Lindgjaerde OC and Lothe RA: The order of genetic events
associated with colorectal cancer progression inferred from
meta-analysis of copy number changes. Genes Chromosomes Cancer.
45:31–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giannini G, Ambrosini MI, Di Marcotullio
L, Cerignoli F, Zani M, MacKay AR, Screpanti I, Frati L and Gulino
A: EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a
conserved gene family and is overexpressed and amplified in breast
and ovarian cancer. Mol Carcinog. 38:188–200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu N, Roth MJ, Emmert-Buck MR, Tang ZZ,
Polymeropolous M, Wang QH, Goldstein AM, Han XY, Dawsey SM, Ding T,
Giffen C and Taylor PR: Allelic loss in esophageal squamous cell
carcinoma patients with and without family history of upper
gastrointestinal tract cancer. Clin Cancer Res. 5:3476–3482.
1999.PubMed/NCBI
|
|
11
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
12
|
Jiang JK, Chen YJ, Lin CH, Yu IT and Lin
JK: Genetic changes and clonality relationship between primary
colorectal cancers and their pulmonary metastases - an analysis by
comparative genomic hybridization. Genes Chromosomes Cancer.
43:25–36. 2005. View Article : Google Scholar
|
|
13
|
Jiang LX, Xu J, Wang ZW, Li DP, Peng ZH,
Gao JJ, He L and Zheng HT: Tumor suppress genes screening analysis
on 4q in sporadic colorectal carcinoma. World J Gastroenterol.
14:5606–5611. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawakami M, Yamaguchi T, Takahashi K,
Matsumoto H, Yasutome M, Horiguchi S, Hayashi Y, Funata N and Mori
T: Assessment of SMAD4, p53, and Ki-67 alterations as a predictor
of liver metastasis in human colorectal cancer. Surg Today.
40:245–250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kimura Y, Noguchi T, Kawahara K, Kashima
K, Daa T and Yokoyama S: Genetic alterations in 102 primary gastric
cancers by comparative genomic hybridization: gain of 20q and loss
of 18q are associated with tumor progression. Mod Pathol.
17:1328–1337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Knosel T, Schluns K, Dietel M and Petersen
I: Chromosomal alterations in lung metastases of colorectal
carcinomas: associations with tissue specific tumor dissemination.
Clin Exp Metastasis. 22:533–538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lagerstedt KK, Staaf J, Jonsson G, Hansson
E, Lonnroth C, Kressner U, Lindstrom L, Nordgren S, Borg A and
Lundholm K: Tumor genome wide DNA alterations assessed by array CGH
in patients with poor and excellent survival following operation
for colorectal cancer. Cancer Inform. 3:341–355. 2007.PubMed/NCBI
|
|
18
|
Lei T, Chen WQ, Zhang SW, Lei TH, Ying Q,
He ZY and Wang XH: Prevalence trend of colorectal cancer in 10
cities and counties in China from 1988 to 2002. Zhonghua Zhong Liu
Za Zhi. 31:428–433. 2009.(In Chinese).
|
|
19
|
Lengauer C, Kinzler KW and Vogelstein B:
Genetic instability in colorectal cancers. Nature. 386:623–627.
1997. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lengauer C, Kinzler KW and Vogelstein B:
Genetic instabilities in human cancers. Nature. 396:643–649. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li HL, Gao YT, Zheng Y, Zhang W, Gao LF,
Xu B and Xiang YB: Incidence trends of colorectal cancer in urban
Shanghai, 1973–2005. Zhonghua Yu Fang Yi Xue Za Zhi. 43:875–879.
2009.(In Chinese).
|
|
22
|
Losi L, Bouzourene H and Benhattar J: Loss
of Smad4 expression predicts liver metastasis in human colorectal
cancer. Oncol Rep. 17:1095–1099. 2007.PubMed/NCBI
|
|
23
|
Nakao M, Kawauchi S, Furuya T, Uchiyama T,
Adachi J, Okada T, Ikemoto K, Oga A and Sasaki K: Identification of
DNA copy number aberrations associated with metastases of
colorectal cancer using array CGH profiles. Cancer Genet Cytogenet.
188:70–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakao M, Kawauchi S, Uchiyama T, Adachi J,
Ito H, Chochi Y, Furuya T, Oga A and Sasaki K: DNA copy number
aberrations associated with the clinicopathological features of
colorectal cancers: Identification of genomic biomarkers by
array-based comparative genomic hybridization. Oncol Rep.
25:1603–1611. 2011.
|
|
25
|
Petersen S, Aninat-Meyer M, Schluns K,
Gellert K, Dietel M and Petersen I: Chromosomal alterations in the
clonal evolution to the metastatic stage of squamous cell
carcinomas of the lung. Br J Cancer. 82:65–73. 2000.PubMed/NCBI
|
|
26
|
Rae FK, Hooper JD, Nicol DL and Clements
JA: Characterization of a novel gene, STAG1/PMEPA1, upregulated in
renal cell carcinoma and other solid tumors. Mol Carcinog.
32:44–53. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rothlisberger B, Heizmann M, Bargetzi MJ
and Huber AR: TRIB1 overexpression in acute myeloid leukemia.
Cancer Genet Cytogenet. 176:58–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang Y, Shu G, Yuan X, Jing N and Song J:
FOXA2 functions as a suppressor of tumor metastasis by inhibition
of epithelial-to-mesenchymal transition in human lung cancers. Cell
Res. 21:316–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu LL, Shanmugam N, Segawa T, Sesterhenn
IA, McLeod DG, Moul JW and Srivastava S: A novel androgen-regulated
gene, PMEPA1, located on chromosome 20q13 exhibits high level
expression in prostate. Genomics. 66:257–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yokoyama T, Kanno Y, Yamazaki Y, Takahara
T, Miyata S and Nakamura T: Trib1 links the MEK1/ERK pathway in
myeloid leukemogenesis. Blood. 116:2768–2775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang B, Halder SK, Kashikar ND, Cho YJ,
Datta A, Gorden DL and Datta PK: Antimetastatic role of Smad4
signaling in colorectal cancer. Gastroenterology. 138:969–980.
2010. View Article : Google Scholar : PubMed/NCBI
|
